Last update:

Diseases, Conditions, Syndromes news

Diseases, Conditions, Syndromes

Long COVID patients with abnormal lung CT scans could prove key to preventing pulmonary fibrosis

Long COVID occurs in approximately a third of COVID-19 survivors, with the CDC estimating one in 13 adults in the United States have long COVID symptoms such as brain fog, shortness of breath and chest pain. In a new study ...

Genetics

Scrutinizing cells for clues to a treatment for muscular dystrophy

A research team led by Associate Professor Hidetoshi Sakurai and Researcher Nana Takenaka-Ninagawa recently demonstrated the superior therapeutic potential of iPS cell-derived mesenchymal stromal cells (iMSCs) compared to ...

Diseases, Conditions, Syndromes

U.S. overdose deaths drop 10% in early data

In findings that suggest inroads are being made in the battle against America's opioid epidemic, new government data shows a 10% drop in overdose deaths.

Diseases, Conditions, Syndromes

Scurvy: Not just an 18th-century sailors' disease

Scurvy, or vitamin C deficiency, is not just an 18th-century seafarers' disease, as a case study of a 65-year-old woman with mobility issues and social isolation shows. In an article published in Canadian Medical Association ...

Diseases, Conditions, Syndromes

Mpox epidemic: from first cases to vaccinations

As the Democratic Republic of Congo launches a vaccination campaign amid a flare-up of the sometimes deadly illness mpox, AFP looks at how the virus developed.

Diseases, Conditions, Syndromes

Biomarker can help health care assess severity of COVID-19

Researchers at Karolinska Institutet and the University of Gothenburg have identified a biomarker that could become an important tool for health care in assessing patients with acute COVID-19 infection. The researchers have ...

Diseases, Conditions, Syndromes

WHO approves first mpox diagnostic test

The UN health agency said on Friday that it had approved the use of the first diagnostic test for mpox, a key tool in countries battling outbreaks.

Diseases, Conditions, Syndromes

Biden administration launches office for long COVID research

As Americans continue to grapple with the effects of long COVID, the Biden administration on Monday announced the creation of a new office focused on research about the condition that will be part of the U.S. Department of ...

Diseases, Conditions, Syndromes

Protein inhibits development of COVID-19 in live animals

A mammalian protein previously shown by UT Southwestern microbiologists to inhibit the virus that causes COVID-19 in cell culture also protected live mouse models, significantly limiting infection in the lung cells and diminishing ...

Diseases, Conditions, Syndromes

Q&A: What's in store for the upcoming respiratory virus season?

Last year's "tripledemic" of flu, COVID-19 and RSV left many of us wary of what the coming respiratory virus season might bring. But this year's landscape is already different, with new vaccines and treatments, like the game-changing ...

Diseases, Conditions, Syndromes

Consumer Health: Are you at risk for hepatitis?

Hepatitis is inflammation of the liver. The five main strains of the hepatitis virus are referred to as types A, B, C, D and E. While they all cause liver disease, they differ in geographic prevalence, modes of transmission, ...

Diseases, Conditions, Syndromes

How austerity made the UK more vulnerable to COVID

The concept of austerity featured prominently in the first round of hearings of the UK's COVID inquiry, which has recently come to a close. Notably, former chancellor George Osborne claimed that austerity had a "positive" ...

Diseases, Conditions, Syndromes

Neonatal stem cells from the heart could treat Crohn's disease

Research from Ann & Robert H. Lurie Children's Hospital of Chicago found that direct injection of neonatal mesenchymal stem cells, derived from heart tissue discarded during surgery, reduces intestinal inflammation and promotes ...

Diseases, Conditions, Syndromes

Investigating acute hepatitis of unknown origin in children

Since Fall 2021, an increasing number of unexplained cases of severe acute hepatitis have been reported in children. Epidemiologic investigation is ongoing, and, to date, a cause of these outbreaks has not been identified. ...